BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32800318)

  • 21. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor.
    Regolisti G; Cabassi A; Parenti E; Maggiore U; Fiaccadori E
    Am J Kidney Dis; 2010 Jul; 56(1):168-74. PubMed ID: 20493607
    [No Abstract]   [Full Text] [Related]  

  • 22. Tetany, hypomagnesemia, and proton-pump inhibitors.
    Famularo G; Minisola G; Bravi MC; Colucci P; Gasbarrone L
    Am J Med; 2012 Oct; 125(10):e7-8. PubMed ID: 22800870
    [No Abstract]   [Full Text] [Related]  

  • 23. Torsade de pointes and long QT syndrome following major blood transfusion.
    Kulkarni P; Bhattacharya S; Petros AJ
    Anaesthesia; 1992 Feb; 47(2):125-7. PubMed ID: 1539780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
    Doornebal J; Bijlsma R; Brouwer RM
    Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review.
    William JH; Danziger J
    J Clin Pharmacol; 2016 Jun; 56(6):660-8. PubMed ID: 26582556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Severe heart arrhythmia secondary to magnesium depletion. Torsade de pointes].
    Papaceit J; Moral V; Recio J; de Ferrer JM; Riva J; Bayés de Luna A
    Rev Esp Anestesiol Reanim; 1990; 37(1):28-31. PubMed ID: 2326522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitors and severe hypomagnesaemia.
    Cundy T; Mackay J
    Curr Opin Gastroenterol; 2011 Mar; 27(2):180-5. PubMed ID: 20856115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hypomagnesemia.
    Ayuk J; Gittoes NJ
    Am J Kidney Dis; 2014 Apr; 63(4):691-5. PubMed ID: 24100128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypomagnesemia Following Prolonged Use of Proton-pump Inhibitors.
    Janett S; Bianchetti MG; Milani GP; Lava SA
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):e39. PubMed ID: 27010402
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.
    Furlanetto TW; Faulhaber GA
    Arch Intern Med; 2011 Aug; 171(15):1391-2. PubMed ID: 21555654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prevalence of Hypomagnesemia in Hospitalized Type 2 Diabetic Patients Treated with Diuretics and/or Proton Pump Inhibitors.
    Mengesha B; Levi D; Kroonenberg M; Koren R; Golik A; Koren S
    Isr Med Assoc J; 2021 Apr; 23(4):245-250. PubMed ID: 33899358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.
    Snitker S; Doerfler RM; Soliman EZ; Deo R; St Peter WL; Kramlik S; Fischer MJ; Navaneethan S; Delafontaine P; Jaar BG; Ojo A; Makos GK; Slaven A; Weir MR; Zhan M; Fink JC;
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1409-1417. PubMed ID: 28793999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypomagnesaemia due to use of proton pump inhibitors--a review.
    Kuipers MT; Thang HD; Arntzenius AB
    Neth J Med; 2009 May; 67(5):169-72. PubMed ID: 19581665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
    Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
    Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors and hypomagnesemia in patients with arrhythmias.
    Ragupathi L; Fonseka N; Sendecki JA; McCarey MM; Breecker SW; Whellan DJ
    Int J Clin Pract; 2015 Dec; 69(12):1525-6. PubMed ID: 26647010
    [No Abstract]   [Full Text] [Related]  

  • 37. Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
    Fatuzzo P; Portale G; Scollo V; Zanoli L; Granata A
    J Nephrol; 2017 Apr; 30(2):297-301. PubMed ID: 27206762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death.
    Singh BN; Hollenberg NK; Poole-Wilson PA; Robertson JI
    J Hypertens; 1992 Apr; 10(4):301-16. PubMed ID: 1316396
    [No Abstract]   [Full Text] [Related]  

  • 39. The Relationship Between Resistant Tachycardia and Treatment for GERD.
    Elliott EM
    Explore (NY); 2016; 12(6):456-458. PubMed ID: 27693368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptomatic hypomagnesemia induced by proton-pump inhibitors (PPIs). A known adverse event that is worth recalling.
    Keco Huerga A; García de la Borbolla Serres J; Castro Fernández M
    Rev Esp Enferm Dig; 2021 Oct; 113(10):728-729. PubMed ID: 33720741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.